Legal & General Group PLC Marker Therapeutics, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$1.88 - $3.56 $5,147 - $9,747	-2,738 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.47 - $3.29 $805 - $1,802	-548 Reduced 16.68%	2,738 $6,000
Q3 2020 Nov 13, 2020	SELL	$1.5 - $2.2 $2,884 - $4,230	-1,923 Reduced 36.92%	3,286 $5,000
Q1 2020 May 14, 2020	SELL	$1.59 - $3.35 $572 - $1,206	-360 Reduced 6.46%	5,209 $10,000
Q4 2019 Feb 13, 2020	BUY	$2.68 - $4.85 $2,779 - $5,029	1,037 Added 22.88%	5,569 $16,000
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $23,339 - $35,893	4,532 New	4,532 $36,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $275M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.